Larimar Therapeutics, Inc. — Director's Dealing 2015

Jul 15, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ZAFGEN, INC. (ZFGN)
CIK: 0001374690
Period of Report: 2015-07-13

Reporting Person: Barrett Peter (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-07-13	Stock Option (Right to Buy)	$37.15	A	12000	Acquired	2025-07-13	Common Stock (12000)	Direct

Footnotes

F1: These options were issued under the nonemployee director compensation policy and will vest in full upon the earlier of the first anniversary of the date of the 2015 annual meeting of stockholders or the date of the 2016 annual meeting of stockholders.